CASE DISCUSSION
Airway Management in the ICU
Presented from by Dr. Nikhilesh Jain
Views
5,730
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Airway management in the ICU is critical for patients with respiratory failure, altered consciousness, or severe illness. Endotracheal intubation is the most common method, often performed using rapid sequence induction with appropriate sedation and neuromuscular blockade. Pre-oxygenation and...
Case Summary
- The speaker emphasizes the importance of airway management in the ICU, focusing on intubation and ventilation. They limit the discussion to procedures within the ICU, excluding super-aglottic airway devices and focusing on the specific problems faced in the critical care setting. The key reasons for intubation are failure to maintain a patent airway, ventilation or oxygenation failure, and anticipation of airway worsening.
Speaker Profile
Dr. Nikhilesh Jain
Alumni - Royal College of PhysiciansDirector and Consultant Dept of Critical Care at CHL Hospitals, Indore
Dr. Nikhilesh Jain is a distinguished Physician Intensivist with over 20 years of experience in critical care medicine. He currently serves as Director and Operational Head of the Department of Critical Care Services at CARE CHL Hospitals, Indore. He completed his MBBS from Gandhi Medical College, Bhopal, followed by DNB (Medicine) from Apollo Hospitals, Chennai, and MRCP (Ireland). He also holds IDCCM, FCCCM, and FIECMO qualifications. His special interests include Hemodynamic Monitoring, ECMO, Infectious Diseases and Sepsis, Critical Care Ultrasound, and Multi-Organ Transplants. He has over 65 national and international publications, book chapters, and serves as a journal reviewer for Cureus and Neurocritical Care Society. He is a DNB teacher in Critical Care, has served as Past Secretary and President of ISCCM (Indore Chapter), and is a member of prestigious societies including SCCM (USA), ESICM, ISCCM, NCS, and ATS. He is also involved with ROTTO and SOTTO, India\'s premier organ transplant organizations.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.